Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $55

Axogen, Inc.

Axogen, Inc.

AXGN

0.00

Canaccord Genuity analyst Caitlin Roberts maintains Axogen (NASDAQ: AXGN) with a Buy and raises the price target from $50 to $55.